levalbuterol has been researched along with albuterol in 11 studies
| Studies (levalbuterol) | Trials (levalbuterol) | Recent Studies (post-2010) (levalbuterol) | Studies (albuterol) | Trials (albuterol) | Recent Studies (post-2010) (albuterol) |
|---|---|---|---|---|---|
| 24 | 5 | 19 | 10,108 | 3,059 | 2,058 |
| Protein | Taxonomy | levalbuterol (IC50) | albuterol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 1.2618 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 5 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| Bollu, V; Braman, SS; Ernst, FR; Karafilidis, J; Rajagopalan, K; Robinson, SB | 1 |
| Brunetti, L; Dhanaliwala, F; Kang, H; Poiani, G; Poppiti, K; Suh, DC | 1 |
| Arroyo, MG; Couëtil, LL; Ivester, KM; Kamarudin, MM; Nogradi, N | 1 |
| Love, BL; Lu, ZK; Schulz, RM; Wu, J; Yuan, J; Zhang, Y | 1 |
| Campbell, S; Kirkland, SW; Nikel, T; Rowe, BH; Vandenberghe, C; Voaklander, B | 1 |
| Hotz, J; Khemani, RG; Newth, CJ; Ross, PA; Virk, MK | 1 |
| Gandhi, S; Graden, A; Joshi, AY | 1 |
| Gamboa, DG; Johnson, MD; Mundorff, M; Weng, C; Woodward, S | 1 |
| Ali, MM; Farzana, S; Hossain, AJ; Islam, MS; Nahar, A; Rabbany, MA; Saha, BK; Seraj, S; Sharmin, M; Siddiqui, KA; Subha, N; Sultana, I | 1 |
| Esaulova, NA; Leshchenko, IV; Viktorova, IA; Zaitsev, AA | 1 |
| Beng, H; Hu, J; Liang, X; Qin, H; Tan, W; Wang, S | 1 |
1 review(s) available for levalbuterol and albuterol
| Article | Year |
|---|---|
Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Anti-Asthmatic Agents; Asthma; Atropine; Cholinergic Antagonists; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Ipratropium; Levalbuterol; Metaproterenol; Randomized Controlled Trials as Topic; Scopolamine Derivatives | 2017 |
5 trial(s) available for levalbuterol and albuterol
| Article | Year |
|---|---|
Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with chronic obstructive pulmonary disease or asthma.
Topics: Adolescent; Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Female; Hospitalization; Humans; Length of Stay; Levalbuterol; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Treatment Outcome; Young Adult | 2015 |
Efficacy of Inhaled Levalbuterol Compared to Albuterol in Horses with Recurrent Airway Obstruction.
Topics: Albuterol; Animals; Bronchodilator Agents; Cross-Over Studies; Female; Horse Diseases; Horses; Levalbuterol; Lung Diseases, Obstructive; Male | 2016 |
Change in Oxygen Consumption Following Inhalation of Albuterol in Comparison with Levalbuterol in Healthy Adult Volunteers.
Topics: Administration, Inhalation; Adult; Albuterol; Bronchodilator Agents; Healthy Volunteers; Heart Rate; Humans; Levalbuterol; Middle Aged; Oxygen Consumption; Prospective Studies; Single-Blind Method; Young Adult | 2017 |
Comparative Efficacy of Levosalbutamol and Racemic Salbutamol in the Treatment of Acute Exacerbation of Asthma.
Topics: Acute Disease; Administration, Inhalation; Adult; Albuterol; Asthma; Bangladesh; Bronchodilator Agents; Child; Double-Blind Method; Humans; Levalbuterol | 2023 |
[Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronch
Topics: Acute Disease; Adult; Albuterol; Ambroxol; Bromhexine; Bronchitis; Cough; Drug Combinations; Expectorants; Guaifenesin; Humans; Levalbuterol; Treatment Outcome | 2023 |
5 other study(ies) available for levalbuterol and albuterol
| Article | Year |
|---|---|
Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Aged; Albuterol; Bronchodilator Agents; Chi-Square Distribution; Comparative Effectiveness Research; Ethanolamines; Female; Formoterol Fumarate; Humans; Levalbuterol; Logistic Models; Lung; Male; Middle Aged; Multivariate Analysis; Nebulizers and Vaporizers; Odds Ratio; Patient Readmission; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; United States | 2013 |
Clinical outcomes of levalbuterol versus racemic albuterol in pediatric patients with asthma: Propensity score matching approach in a medicaid population.
Topics: Adolescent; Albuterol; Asthma; Bronchodilator Agents; Child; Child, Preschool; Cohort Studies; Emergency Service, Hospital; Female; Hospitalization; Humans; Levalbuterol; Male; Medicaid; Propensity Score; Retrospective Studies; South Carolina; Treatment Outcome; United States | 2017 |
Case report: Paradoxical responses to short acting beta-agonists in a pediatric patient.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Asthma; Bronchodilator Agents; Child; Female; Humans; Ipratropium; Levalbuterol | 2021 |
Incidence of supraventricular tachycardia after inhaled short-acting beta agonist treatment in children.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Asthma; Body Mass Index; Child; Child, Preschool; Female; Humans; Incidence; Infant; Levalbuterol; Male; Racial Groups; Risk Factors; Tachycardia, Supraventricular | 2021 |
Effects of R-salbutamol on the inflammatory response and acute lung injury in endotoxemic mice.
Topics: Acute Lung Injury; Albuterol; Animals; Cytokines; Endotoxemia; Levalbuterol; Lipopolysaccharides; Lung; Mice | 2023 |